Session 4: Pediatric Psychopharmacology Update (July 28-29)
The ability to comfortably provide pharmacotherapy for child mental health problems is now a critical skill for primary care clinicians of all disciplines. This symposium will review advances in the use of medications for both commonly seen and more unusual mental health disorders. Emphasis will be placed on the underlying pharmacokinetic and pharmacodynamic principles that can guide care. Challenging clinical vignettes will be the base for discussions. Participants are encouraged to bring their own ‘problem cases’ for discussion by the group.
Thursday Philosophy of safe and effective psychopharmacology; Treatment of attention and disruptive behavior disorders; Approaches to affective and mood disorders
Friday Pharmacotherapy for Autism Spectrum Disorders; Coordinating care for tic disorders; Pediatric sleep disorders; Participant cases
Accreditation and Designation of Credit:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 8 AMA PRA Category 1 Creditstm. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 8 hours of participation for continuing education for allied health professionals.
The Medical College of Wisconsin is approved by the American Psychological Association to sponsor continuing education for psychologists. MCW maintains responsibility for this program and its content. This activity contains content or processes that may be potentially stressful.
The Medical College of Wisconsin is registered with the Illinois Department of Professional Regulation as a Continuing Education Sponsor for social workers (license number 159-000664).
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
Tuition includes course materials and continental breakfast.
Purchase an additional 5 DAY session and receive a $100.00 discount. Use coupon code: +DCSI
Please note: A $10.00 non-refundable processing fee is assessed on registrations.
This advanced seminar is geared to mental health and health professionals.
- Discuss and apply the competing pharmacodynamic explanations for the effects of stimulants in attention disorders
- Cite resources for assessing potential drug:drug interactions impacting co-pharmacy decision making in clinical practice
- Appreciate the need for strong collaboration between a patient’s ‘medical home’, school, and mental health resources
- Recognize when consultation with an ‘expert’ pharmacotherapist is needed and identify resources available
Richard Barthel, MD, is Assistant Professor in the MCW Department of Psychiatry, Division of Child and Adolescent Psychiatry. His clinical work is based at the MCW Tosa Center where he follows patients via telemedicine at Catalpa Health and Wellness, a child mental health clinic in Appleton, WI. This follows 30+ years at Children’s Hospital of Wisconsin. He is an ongoing teacher of child and adolescent psychopharmacology to child psychiatry fellows.
All persons in control of content have NO relevant financial relationships to disclose.
- 8.00 AAFPAAFP credit.
- 8.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 8.00 APAAPA credit.
- 8.00 Hours of ParticipationHours of Participation credit.